Oficiálny časopis Slovenskej kardiologickej spoločnosti,
Slovenskej hypertenziologickej spoločnosti a Slovenskej asociácie srdcových arytmií

Cardiology Letters 2020, 29(5):293-302

Gerontokardiológia: COVID-19

Dúbrava M1, Jánošiová J1, Koščálová A2, Šuba J ml.1
1 I. klinika geriatrie LFUK a UN Bratislava
2 Klinika infektológie a geografickej medicíny UNB, LFUK a SZU Bratislava, Slovenská republika

Od decembra 2019 ochorenie COVID-19 spôsobené "novým vírusom" SARS-CoV-2 zásadne zmenilo fungovanie sveta. Zväčša je síce asymptomatické alebo sprevádzané miernymi príznakmi, máva však aj ťažký priebeh s následnou letalitou. Osobitne rizikoví voči tejto infekcii sú seniori. COVID-19 sa dominantne prejavuje postihnutím respiračného systému, často sú však poškodené aj iné orgánové systémy, medzi nimi kardiovaskulárny. V tejto stati ponúkame jeden z možných pohľadov na to, čo vieme o kardiovaskulárnych prejavoch COVID-19 u seniorov.

Kľúčové slová: COVID-19; kardiovaskulárny systém; myokard; arytmie; trombóza; geriatria; senior

Uverejnené: May 1, 2020  Zobraziť citáciu

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dúbrava M, Jánošiová J, Koščálová A, Šuba J. Gerontokardiológia: COVID-19. Cardiology Letters. 2020;29(5-6):293-302.
Share...
Stiahnuť citáciu
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobraziť celý článok

    Referencie

    1. Hlivák P. COVID-19 - editoriál prezidenta SKS. Cardiology Lett 2020;29:69-72.
    2. Bonanad C, García-Blas S, Tarazona-Santabalbina FJ, et al. Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology. Rev Esp Cardiol 2020;73:569-576. Prejsť k pôvodnému zdroju...
    3. Moccia F, Gerbino A, Lionetti V, et al. COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. Geroscience 2020;42:1021-1049. Prejsť k pôvodnému zdroju...
    4. Dúbrava M, Celec P, Pastorek M, et al. COVID-19, NET a GER. Geriatria 2020;26: v tlači.
    5. Report of clustering pneumonia of unknown etiology in Wuhan City. Wuhan Municipal Health Commission, 2019. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989.
    6. Zhu N, Zhang D, Wang W, et al. A Novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727733. Prejsť k pôvodnému zdroju...
    7. Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020;323:1574-1581. Prejsť k pôvodnému zdroju...
    8. Inde Z, Yapp C, Joshi GN, et al. Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 disease severity. bioRxiv [Preprint] 2020;2020.09.13.276923. Prejsť k pôvodnému zdroju...
    9. Su YB, Kuo MJ, Lin TY, et al. Cardiovascular manifestation and treatment in COVID-19. J Chin Med Assoc 2020 Aug; 83:704-709. Prejsť k pôvodnému zdroju...
    10. Delcuve GP, Lakowski TM, Su RC, et al. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities. IUBMB Life 2020. doi: 10.1002/iub.2380. Epub ahead of print. Prejsť k pôvodnému zdroju...
    11. Liu J, Tao L, Gao Z, et al. Development and validation of a prediction model for early identification of critically ill elderly COVID-19 patients. Aging (Albany NY) 2020; doi: 10.18632/aging.103716. Epub ahead of print. Prejsť k pôvodnému zdroju...
    12. Mendes A, Serratrice C, Herrmann FR, et al. Predictors of inhospital mortality in older patients with COVID-19: The COVIDAge Study. J Am Med Dir Assoc 2020; published online ahead of print doi:10.1016/j.jamda.2020.09.014. Prejsť k pôvodnému zdroju...
    13. Dušek L. Datová a informační základna pro management pandemie COVID-19. Shrnutí současné epidemiologické situace dle dostupných dat. 71. schůze Výboru pro zdravotnictví Parlamentu České republiky - Poslanecká sněmovna, 23.9.2020. https://www.psp.cz/sqw/hp.sqw?k=3206&ido=1316&td=22&cu=71
    14. Liang WH, Guan WJ, Li CC, et al. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China. Eur Respir J 2020;55:2000562. Prejsť k pôvodnému zdroju...
    15. https://covid-19.nczisk.sk/sk
    16. https://qap.ecdc.europa.eu/public/extensions/COVID-19/COVID-19.html#enhanced-surveillance-tab
    17. http://statdat.statistics.sk/
    18. Chovancová Z. Imunosenescence - západ slunce nad imunitním systémem. Vnitř Lék 2020;66:353-358. Prejsť k pôvodnému zdroju...
    19. Palmieri L, Vanacore N, Donfrancesco C, et al. Clinical characteristics of hospitalized individuals dying with COVID-19 by age group in Italy. J Gerontol A Biol Sci Med Sci 2020;75:17961800. Prejsť k pôvodnému zdroju...
    20. Sepulveda ER, Stall NM, Sinha SK. A comparison of covid-19 mortality rates among long-term care residents in 12 oecd countries. J Am Med Dir Assoc 2020; published online ahead of print doi:10.1016/j.jamda.2020.08.039. Prejsť k pôvodnému zdroju...
    21. Stern C, Klein DB. Stockholm city's elderly care and Covid19: Interview with Barbro Karlsson. Society 2020;Jul 19(1-12). Prejsť k pôvodnému zdroju...
    22. Ciminelli G, Garcia-Mandicó S. COVID-19 in Italy: An Analysis of Death Registry Data. J Public Health (Oxf) 2020: fdaa165. Epub ahead of print. Prejsť k pôvodnému zdroju...
    23. Bonafè M, Prattichizzo F, Giuliani A, et al. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev 2020;53:33-37. Prejsť k pôvodnému zdroju...
    24. Xie J, Tong Z, Guan X, et al. Clinical characteristics of patients who died of coronavirus disease 2019 in China. JAMA Netw Open 2020;3:e205619. Prejsť k pôvodnému zdroju...
    25. Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:458-464. Prejsť k pôvodnému zdroju...
    26. Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis 2020;20:669-677. Prejsť k pôvodnému zdroju...
    27. Levin AT, Hanage WP, Owusu-Boaitey N, et al. Assessing the Age Specificity of Infection Fatality Rates for COVID-19: Systematic Review, Meta-Analysis, and Public Policy Implications. MedRxiv preprint doi: https://doi.org/10.1101/2020.07.23.20160895
    28. Eurostat. Weekly deaths statistics - March to June 2020. Almost 170 000 additional deaths in the EU. A peak in late March - early April. Newsrelease 2020; 155. https://ec.europa.eu/eurostat/documents/2995521/11438257/3-19102020-BP-EN. pdf/ cc763e0b-38c3-f99f-1f9c-81fa5f3d3850.
    29. WHO. Interanational guidelines for certification and classification (coding) of COVID-19 as cause of death. https://www.who.int/classifications/icd/COVID-19/en/.
    30. Luo H, Liu S, Wang Y, et al. Age differences in clinical features and outcomes in patients with COVID-19, Jiangsu, China: a retrospective, multicentre cohort study. BMJ Open 2020;10:e039887. Prejsť k pôvodnému zdroju...
    31. Boëlle PY, Delory T, Maynadier X, et al. Trajectories of Hospitalization in COVID-19 Patients: An Observational Study in France. J Clin Med 2020;9:E3148. Prejsť k pôvodnému zdroju...
    32. Benetos A, Martin F, Sieber C, et al. Statement of the EuGMS Executive Board on the COVID-19 epidemic. https://www.eugms.org/news/read/article/489.html.
    33. Wei C, Liu Y, Liu Y, et al. Clinical characteristics and manifestations in older patients with COVID-19. BMC Geriatr 2020;20:395. Prejsť k pôvodnému zdroju...
    34. Wang L, He W, Yu X, et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. J Infect 2020;8:639-645. Prejsť k pôvodnému zdroju...
    35. Moula AI, Micali LR, Matteucci F, et al. Quantification of death risk in relation to sex, pre-existing cardiovascular diseases and risk factors in COVID-19 patients: Let's take stock and see where we are. J Clin Med 2020;9:E2685. Prejsť k pôvodnému zdroju...
    36. Calcaterra G, Bassareo PP, Barilla F, et al. The deadly quartet (Covid-19, old age, lung disease, and heart failure) explain why coronavirus-related mortality in northern Italy was so high. Curr Cardiol Rev 2020; epub ahead of print: doi: 10.2174/1573403X16666200731162614. Prejsť k pôvodnému zdroju...
    37. Emilsson V, Gudmundsson EF, Aspelund T, et al. ACE2 levels are altered in comorbidities linked to severe outcome in COVID-19. medRxiv 2020; [Preprint] 2020.06.04.20122044. Prejsť k pôvodnému zdroju...
    38. Napoli C, Tritto I, Benincasa G, et al. Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review. Ann Med Surg (Lond) 2020;57236 -243. Prejsť k pôvodnému zdroju...
    39. Deshmukh V, Motwani R, Kumar A, et al. Histopathological observations in COVID-19: a systematic review. J Clin Pathol 2020: jclinpath-2020-206995. Prejsť k pôvodnému zdroju...
    40. Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020;5:802-810. Prejsť k pôvodnému zdroju...
    41. Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:811-818. Prejsť k pôvodnému zdroju...
    42. Zhao M, Wang M, Zhang J, et al. Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages. Aging (Albany NY) 2020; 12:10070-10086. Prejsť k pôvodnému zdroju...
    43. Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:811-818. Prejsť k pôvodnému zdroju...
    44. Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med 2020;382:23722374. Prejsť k pôvodnému zdroju...
    45. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061-1069. Prejsť k pôvodnému zdroju...
    46. Rav-Acha M, Orlev A, Itzhaki I, et al. Cardiac arrhythmias among hospitalized Coronavirus 2019 (COVID-19) patients: prevalence, characterization, and clinical algorithm to classify arrhythmic risk. Int J Clin Pract 2020; epub ahead of print: e13788. Prejsť k pôvodnému zdroju...
    47. Stadler K, Ha HR, Ciminale V, et al. Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a postendosomal level. Am J Respir Cell Mol Biol 2008;39:142-149. Prejsť k pôvodnému zdroju...
    48. Rey JR, Caro-Codón J, Rosillo SO, et al. Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications. Eur J Heart Fail 2020; Epub ahead of print: 10.1002/ejhf.1990. doi: 10.1002/ejhf.1990. Prejsť k pôvodnému zdroju...
    49. Chatrath N, Kaza N, Pabari PA, et al. The effect of concomitant COVID-19 infection on outcomes in patients hospitalized with heart failure. ESC Heart Fail 2020; epub ahead of print: 10.1002/ ehf2.13059. Prejsť k pôvodnému zdroju...
    50. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129-2200. Prejsť k pôvodnému zdroju...
    51. Hacquin A, Putot S, Barben J, et al. Bedside chest ultrasound to distinguish heart failure from pneumonia-related dyspnoea in older COVID-19 patients. ESC Heart Fail 2020; epub ahead of print: doi: 10.1002 / ehf2.13017. Prejsť k pôvodnému zdroju...
    52. Napoli C, Cacciatore F, Bonaduce D, et al. Efficacy of thrombolysis in younger and older adult patients suffering their first acute qwave myocardial infarction. J Am Geriatr Soc 2002;50:343-348. Prejsť k pôvodnému zdroju...
    53. Pinney SP, Giustino G, Halperin JL, et al. Coronavirus historical perspective, disease mechanisms, and clinical outcomes. JACC Focus Seminar. J Am Coll Cardiol 2020;76:1999-2010. Prejsť k pôvodnému zdroju...
    54. Tal S, Spectre G, Kornowski R, et akl. Venous thromboembolism complicated with covid-19: what do we know so far? Acta Haematol 2020;143:417-424. Prejsť k pôvodnému zdroju...
    55. Dúbrava M, Németh F, Drobná T, et al. Vekovo špecifická prevalencia imobility u hospitalizovaných seniorov (Údaje zo štúdie SAFIS). Geriatria 2019;25:13-16.
    56. Dúbrava M, Jánošiová J. Dehydratácia u hospitalizovaných seniorov. Geriatria 2014;20:103-107.
    57. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020;191:145-147. Prejsť k pôvodnému zdroju...
    58. Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 2020 Jun;18:1421-1424. Prejsť k pôvodnému zdroju...
    59. Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 2020;18:1023-1026. Prejsť k pôvodnému zdroju...
    60. Wang J, Hajizadeh N, Moore EE, et al. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series. J Thromb Haemost 2020;18:1752-1755. Prejsť k pôvodnému zdroju...
    61. Rossi R, Coppi F, Talarico M, et al. Protective role of chronic treatment with direct oral anticoagulants in elderly patients affected by interstitial pneumonia in COVID-19 era. Eur J Intern Med 2020; 7:158-160. Prejsť k pôvodnému zdroju...
    62. Liu PP, Blet A, Smyth D, et al. The science underlying COVID-19: Implications for the cardiovascular system. Circulation 2020;142:68-78. Prejsť k pôvodnému zdroju...
    63. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426(6965):450-454. Prejsť k pôvodnému zdroju...
    64. Hoffmann M, Kleine-Weber H, Schroeder, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor [published ahead of print]. Cell 2020. doi: 10.1016/j.cell.2020.02.052. Prejsť k pôvodnému zdroju...
    65. Daly JL, Simonetti B, Klein K, et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 2020; 10.1126/science. abd3072. Prejsť k pôvodnému zdroju...
    66. Hatala R. Otvorený list hlavného odborníka MZ SR pre kardiológiu MUDr. I. Bukovskému, PhD. https://www.sks.sk/news/otvoreny-list-hlavneho-odbornika-mz-sr-pre-kardiologiumudr-i-bukovskemu-phd.
    67. Danser AHJ, Epstein M, Batlle D. Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers. Hypertension 2020;75:1382-1385. Prejsť k pôvodnému zdroju...
    68. Czick M, Shapter C, Shapter R. COVID's Razor: RAS imbalance, the common denominator across disparate, unexpected aspects of COVID-19. Diabetes Metab Syndr Obes 2020;13:3169-3192. Prejsť k pôvodnému zdroju...
    69. Gonçalvesová E, Hlivák P, Hatala R. Stanovisko Slovenskej kardiologickej spoločnosti, Národného ústavu srdcových a cievnych chorôb a. s. a hlavného odborníka MZ SR pre kardiológiu k užívaniu antagonistov renín-angiotenzín-aldosterónového systému (ACE inhibítorov, blokátorov receptora angiotenzínu II - sartanov, ARNI) v čase pandémie ochorenia COVID-19. https://www.sks.sk/news/stanovisko-sks-hlavneho-odbornikamz-sr-pre-kardiologiu-k-uzivaniu-acei-arb-arni.
    70. De Simone G. Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers. 13.3.2020. https://www.escardio.org/ C ouncils/C ouncil-on-Hyp er tension-(CHT)/Ne ws/ position-statement-of-the-esc-council-on-hypertension-onace-inhibitors-and-ang.
    71. Genet B, Vidal JS, Cohen A, et al. COVID-19 in-hospital mortality and use of renin-angiotensin system blockers in geriatrics patients. J Am Med Dir Assoc 2020; published online ahead of print, doi:10.1016/j.jamda.2020.09.004. Prejsť k pôvodnému zdroju...
    72. Dúbrava M, Németh F, Drobná T, et al. Kaliémia u seniorov s fibriláciou predsiení. (Údaje zo štúdie SAFIS.). Geriatria 2018;24:43-50.
    73. Cipriani A, Zorzi A, Ceccato D, et al. Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin. Int J Cardiol 2020;316:280-284. Prejsť k pôvodnému zdroju...
    74. Agrawal U, Raju R, Udwadia ZF. Favipiravir: A new and emerging antiviral option in COVID-19. Med J Armed Forces India 2020;76:370-376. Prejsť k pôvodnému zdroju...
    75. Nguyen FT, van den Akker T, Lally K, et al. Transfusion Reactions Associated with COVID-19 Convalescent Plasma Therapy for SARS-CoV-2. Transfusion 2020; Epub ahead of print: doi: 10.1111/trf.16177. Prejsť k pôvodnému zdroju...
    76. Chorin E, Wadhwani L, Magnani S, et al. QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin. Heart Rhythm 2020;17:1425-1433. Prejsť k pôvodnému zdroju...
    77. Bollmann A, Hohenstein S, König S, et al. In-hospital mortality in heart failure in Germany during the Covid-19 pandemic. ESC Heart Fail. 2020; epub ahead of print: doi: 10.1002/ehf2.13011. Prejsť k pôvodnému zdroju...
    78. Cannatà A, Bromage DI, Rind IA, et al. Temporal trends in decompensated heart failure and outcomes during COVID-19: a multisite report from heart failure referral centres in London. Eur J Heart Fail 2020; epub ahead of print: 10.1002/ejhf.1986. Prejsť k pôvodnému zdroju...
    79. Kontis V, Bennett JE, Rashid T, et al. Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries. Nature medicine 2020. https://doi.org/10.1038/s41591-0201112-0. Prejsť k pôvodnému zdroju...
    80. Dúbrava M, Bořucký J, Šuba J ml. Telemedicína pre seniorov roku 2020. Geriatria 2020;2: v tlači.
    81. Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; Epub ahead of print: e203557.
    82. Unudurthi SD, Luthra P, Bose RJC, et al. Cardiac inflammation in COVID-19: Lessons from heart failure. Life Sci 2020;260:118482. Prejsť k pôvodnému zdroju...
    83. Yancy CW, Fonarow GC. Coronavirus disease 2019 (COVID-19) and the heart-is heart failure the next chapter? JAMA Cardiol 2020; Epub ahead of print: doi: 10.1001/jamacardio.2020.3575. Prejsť k pôvodnému zdroju...

    Späť na obsah